MONOCLONAL ANTIBODY THERAPEUTICS MARKET ANALYSIS
The global monoclonal antibody therapeutics market is estimated to be valued at US$ 205.39 billion in 2023 and is expected to exhibit a CAGR of 12.69% during the forecast period (2023-2030).
Among all segmentation, the application segment has the highest potential due to the increasing prevalence of autoimmune diseases over the forecast period. For instance, in May 2020, according to a report published on National Center for Biotechnology Information (NCBI), autoimmune diseases affect 20% of the total human population in the world.
Figure 1. Global Monoclonal Antibody Therapeutics Market Share (%), By Source, 2023
Figure 2. Global Monoclonal Antibody Therapeutics Market Value (US$ Billion), By Region, 2023
Market Trends
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
